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The  aim  of this  study  was  to develop  hepatocyte-targeting  non-viral  polymeric  nono-carriers  for
gene  delivery.  Chitosan  was  selected  as  the  main  polymer.  An  asialoglycoprotein  receptor  recog-
nized  sugar,  galactose,  was  introduced.  The  methoxy  poly(ethylene  glycol)  (mPEG)  or  short  chain
poly(ethylene  glycol)  diacid  (PEGd)  was  further  grafted  onto  galactosylated  chitosan.  All polyplex
possessed  positive  charge  character.  The  compaction  of  DNA  by grafted  chitosan  was  in order  ofeywords:
hitosan
alactose
ethoxy poly(ethylene glycol)
chitosan-galactose-mPEG  >  chitosan-galactose-PEGd  >  chitosan-galactose  where  the  chitosan-galactose-
mPEG  and pDNA  formed  the most  stable  polyplex.  The  polyplex  prominently  enhanced  DNA
cellular  transfection  as  compared  to  naked  DNA  in  HepG2  cells  in  order  of chitosan-galactose/pDNA
(11.6  ± 0.6–33.0 ± 4.4%)  >  chitosan-galactose-PEGd/pDNA  (12.7  ± 2.5–15.5  ±  3.0%)  > chitosan-galactose-
mPEG/pDNA  (9.0 ±  1.1–12.9  ±  2.4%).
ublisoly(ethylene glycol) diacid
NA transfection
© 2014  The  Authors.  P
. Introduction
Chitosan is a relatively low toxic, biocompatible, and biodegrad-
ble polysaccharide with immunological, antibacterial and wound-
ealing activities. Several strategies have been adopted for
hemical modiﬁcation of chitosan through C2-amino group or
6-hydroxyl group using different substitutes (Gao et al., 2009;
orochovceva & Makus, 2004; Laurentin & Edwards, 2003; Lin
 Chen, 2007; Liu et al., 2009; Park et al., 2003; Sajomsang,
antayanon, Tangpasuthadol, & Daly, 2009). The modiﬁed chi-
osan is applied for drug delivery, tissue engineering, and other
iomedical applications (Alves & Mano, 2008; D’Amelio et al., 2013;
uzzarelli, 2010). The free C2-amino group of chitosan is feasible
o complex with negatively charged DNA as a gene delivery car-
ier. Poly(ethylene glycol) (PEG) is popularly used in pharmaceutics
ue to its hydrophilic character, high solubility, low cytotoxicity
nd good biocompatibility. It was reported that PEG can reduce
rotein opsonization of nanoparticles and subsequent phagocy-
osis by non-parenchymal cells of the liver in vivo. The shielding
ffect of PEG prevents nanoparticles from reticuloendothelium
ystem (RES) uptake resulting in long-circulating characteristics
Avgoustakis, 2004; Betancourt et al., 2009; Ioele, Cione, Risoli,
enchi, & Ragno, 2005; Lu et al., 2009). The similar result has
∗ Corresponding author at: Graduate Institute of Pharmaceutical Sciences, School
f  Pharmacy, National Taiwan University, No. 33 Lin San S. Rd., Taipei 10051, Taiwan.
el.: +886 2 33668765; fax: +886 2 23919098..
E-mail address: wjlin@ntu.edu.tw (W.J. Lin).
ttp://dx.doi.org/10.1016/j.carbpol.2014.11.046
144-8617/© 2014 The Authors. Published by Elsevier Ltd. This is an open access article unhed  by  Elsevier  Ltd. This  is an  open  access  article  under  the CC  BY-NC-ND
license  (http://creativecommons.org/licenses/by-nc-nd/3.0/).
been reported by van Vlerken et al. They found that the pegylated
nanoparticles avoided uptake by RES, thereby improving circula-
tion time of nanoparticles, and the nanoparticles are retained in
the tumor for prolonged period of time (van Vlerken, Duan, Little,
Seiden, & Amiji, 2008). On the other hand, PEG has been used to
improve solubility of chitosan in simulated gastric pH and physio-
logical pH via altering molecular weight and/or substitution degree
of PEG (Casettari et al., 2012; Jeong, Kim, Jang, & Nah, 2008).
Asialoglycoprotein receptor (ASGPR) receives much attention
in gene targeting and also plays as a model system for study-
ing receptor-mediated endocytosis due to its high afﬁnity and
rapid internalization rate. ASGPR is an integral membrane protein
expressed on the surface of parenchymal cells of liver with high
density of 1–5 × 105 receptors (Weigel & Yik, 2002). Nanocarri-
ers (e.g., nanoparticles) with surface modiﬁcation are necessary for
speciﬁc targeting purpose. Several sugar ligands (e.g., galactose, N-
acetylgalactosamine, mannose, lactose, fructose, etc.) have proved
to interact with ASGPR with various extents. Galactose has been
proved recognition of ASGPR through many in vitro and in vivo stud-
ies. Wang et al. (2012) used galactose and PEG modiﬁed liposome
to encapsulate doxorubicin which demonstrated better targeting
efﬁciency and achieved 94% tumor growth inhibition. Jiang et al.
prepared PEG-galactose followed by grafted onto the amino group
of chitosan-PEI. It had better cellular transfection than PEI after
intravenous injection (Jiang et al., 2008). Chen et al. used lacto-
bionic acid and glycyrrhetinic acid to prepare dual-ligand modiﬁed
chitosan. Its transfection efﬁciency in ASGPR high-expressed BEL-
7402 cells was  higher than in ASGPR-free LO2 hepatic normal cells
(Chen et al., 2012).
der the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
8 drate
d
c
n
d
g
Z
w
2
m
l
(
b
(
c
l
a
a
t
H W.J. Lin, W.Y. Hsu / Carbohy
Most of the studies modiﬁed chitosan through C2-NH2 group
ue to simple and easy synthetic procedure. However, the positive
harge of C2-NH2 group plays an important role in complex with
egatively charged DNA for gene delivery. Some studies were
esigned to modify chitosan through C6-OH but leave C2-NH2
roup available for DNA complexation. Jiang, Wu,  Xu, Wang, and
eng (2011) used C6-OH modiﬁed chitosan to complex with various
eight ratios of DNA, and found the molar ratio of polymer/DNA
0:1 expressed the highest cellular transfection. The chemical
odiﬁcation of chitosan by grafting lactobionic acid, as a receptor
igand, through C6-OH position of chitosan has been demonstrated
Lin, Chen, & Liu, 2009; Lin, Chen, Liu, Chen, & Chang, 2011). Lacto-
ionic acid is an endogenous substance present in the human body
Yu & van Scott, 2004). The chemical structure of lactobionic acid
ontains a galactose unit and a gluconic acid unit linked by ether
inkage. The carboxyl group of gluconic acid unit reacts with the
mino group of chitosan to form an amide linkage. The lactobionic
cid grafted chitosan demonstrated higher transfection efﬁciency
han ligand-free chitosan (45.3% vs 19.8%) in ASGPR overexpressed
epG2 cells. Zhang et al. (2009) grafted galactose onto C6-OH
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Fig. 1. Scheme for synthesis of (A) chitosan-galactose, (B) chit Polymers 120 (2015) 7–14
followed by pegylation from C2-NH2 group. They demonstrated no
cytotoxicity of modiﬁed chitosan in HEK 293 kidney cancer cells.
However, it was lack of data to verify the feasible application of
this modiﬁed chitosan in drug and/or gene delivery.
The present study was  aimed to develop a hepatocyte-targeting
non-viral polymeric nano-carrier for gene delivery. Chitosan was
selected as the main polymer. In order to have speciﬁc liver tar-
geting activity, an ASGPR recognized sugar molecule, galactose,
was introduced into C6-OH of chitosan. The hydrophilic methoxy
poly(ethylene glycol) (mPEG) or short chain PEG diacid (PEGd)
was grafted onto galactosylated chitosan further through its C2-
NH2 position to increase solubility and stability of chitosan in vivo.
The synthesized chitosan derivatives were characterized by FTIR,
NMR and GPC, and the galactose, mPEG and PEGd graft contents
were determined. The galactosylated chitosan grafted with mPEG
or PEGd was  applied to complex with plasmid DNA, and the perfor-
mance of polymer/DNA polyplex was  characterized. The ability of
condensing negatively charged plasmid DNA by modiﬁed chitosan,
the stability of polymer/DNA polyplex and its cellular transfection
were evaluated.
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. Materials and methods
.1. Materials
Low molecular weight chitosan (CS, Mw 260 kDa, Mn 72 kDa,
eacetylation degree 76.3 ± 2.1%) and poly(ethylene glycol) diacid
PEGd, Mn 600 Da) were from Aldrich Chemical Company, Inc.,
WI, USA). Methoxy poly(ethylene glycol) (mPEG, MW 5,000 Da),
oron triﬂuoride diethyl ether (BF3•OEt2), and anthrone were from
luka Chemical Company Inc. (Buchs, Switzerland). d(+)-Galactose
99 + %) and N-hydroxysuccinimide (NHS) were from Acros Organ-
cs Co. Inc. (Geel, Belgium). Sodium nitrite (NaNO2) was from
howa Chemical Co. Ltd. (Tokyo, Japan). Sodium cyanoborohy-
ride (NaCNBH3, 95%) was from Alfa Aesara Johnson Matthey Co.
nc. (Massachusetts, USA). 1-Ethyl-3-(3-dimethylaminopropyl car-
odiimide hydrochloride (EDC) was from TCI Chemical Industry
o. Ltd. (Tokyo, Japan). Minimum essential media (MEM)  was from
iological Industries Israel Beit-Haemek Ltd. (Beit HaEmek, Israel).
lasmid encoding enhanced green ﬂuorescent protein (pEGFP-N1,
.7 kb) was kindly provided by Professor Jiin Long Chen from
ational Defense Medical Center in Taiwan. The HepG2 cancer cell
ine was a gift from Dr. Hui-Lin Wu  in Hepatitis Research Center of
ational Taiwan University Hospital in Taiwan.
.2. Synthesis of chitosan-based polymers
Fig. 1(A) shows the procedures to synthesize chitosan-galactose
Chitosan(1)) (Lin et al., 2009, 2011). Chitosan was  deacetylated
n NaOH aqueous solution (50%w/v) at 140 ◦C for 4 h followed by
epolymerized in 0.1 M sodium nitrite acetic solution at room tem-
erature for 3 h. The obtained deacetylated depolymerized chitosan
DADPCS) was reacted with galactose at feed molar ratio 1:2.5 in
he mixture of tetrahydrofuran (THF) and boron triﬂuoride diethyl
therate (BF3•OEt2) at 60 ◦C under N2 for 24 h. The solvent was
emoved by rotary evaporation, and the mixture was dialyzed (MW
ut-off 500-1000 Dalton ) followed by freeze dried.
Fig. 1(B) shows the procedures to synthesize chitosan-galactose-
PEG (Chitosan(2)). mPEG was dissolved in a mixture of DMSO
nd chloroform (10:1, v/v) followed by reacting with acetic
nhydride at room temperature for 9 h. The ether was added
o precipitate the product mPEG-CHO which was collected
fter ﬁltration. The mPEG-CHO was dialyzed (MW cut-off 500-
,000 Da) and freeze dried. Chitosan(1) was previously dissolved
n a mixture of 2% acetic acid and methanol (1:1 v/v). mPEG-
HO in deionized water was slowly added into and reacted at
oom temperature for 3 h followed by adding NaCNBH3 aque-
us solution under N2 for further 18 h. The feed molar ratio of
hitosan(1): mPEG-CHO: NaCNBH3 was 1.0:0.6:4.5. The reaction
olution was concentrated by rotary evaporation, and the mix-
ure was dialyzed (MW  cut-off 6000-8000 Da) followed by vacuum
ried.
galactose DSg1(%) = (samp
galactose DSg2(%) = (sample weight − g
galactose DSg3(%) = (sample weight − gFig. 1(C) shows the procedures to synthesize chitosan-galactose-
EGd (Chitosan(3)). Chitosan(1) was previously dissolved in 1%
cetic acid solution. PEGd, NHS and EDC were slowly added into
nd reacted at room temperature for 24 h. The feed molar ratio Polymers 120 (2015) 7–14 9
of Chitosan(1):PEGd:NHS:EDC was  1:7:7:7. The reaction solution
was dialyzed (MW  cut-off 6000-8000 Da) followed by freeze dried.
The obtained Chitosan(3) was  washed by acetone for three times
followed by vacuum dried.
2.3. Characterization of chitosan-based polymers
The obtained Chitosan(1), Chitosan(2), and Chitosan(3) were
characterized by FTIR and 1H NMR, the molecular weights were
analyzed by GPC. The galactosylation ratio in terms of weight per-
centage (Wg%) was calculated according to Eq. (1). The galactose
degree of substitution (DSg%) of Chitosan(1), Chitosan(2), and Chi-
tosan(3) were determined by anthrone–sulfuric acid colorimetric
assay (Laurentin & Edwards, 2003) and calculated according to Eqs.
(2), (3), and (4), respectively.
Galactose Wg (%) = galactose weight in the samplesample weight × 100% (1)
(galactose weight)/
(
Mw galactose
)
ight − galactose weight)/ (Mw DADPCS monomer)
× 100% (2)
actose weight)/
(
Mw galactose
)
tose weight − mPEG weight)/ (Mw DADPCS monomer)
× 100% (3)
ctose weight)/
(
Mw galactose
)
tose weight − PEGd weight)/ (Mw DADPCS monomer)
× 100% (4)
The mPEG degree of substitution (DSmPEG%) of Chitosan(2) was
calculated by Eq. (5) based on 1H NMR  data, and the pegylation
weight percentage (WmPEG%) was  calculated by Eq. (6).
DSmPEG(%) =
(area of peak c)3.5 ppm/3
(area of peak d)3.2 ppm
× 100% (5)
WmPEG (%) = DSmPEG × Mw mPEG
(DSmPEG × Mw mPEG) + (100% × Mw monomer) +
(
DSg2 × Mw galactose
)
× 100% (6)
Similarly, the PEGd degree of substitution (DSPEGd%) and the
pegylation weight percentage (WPEGd%) of Chitosan(3) were cal-
culated by Eqs. (7) and (8), respectively.
DSPEGd (%) =
(area of peakc′)4.15ppm/2
(area of peak d)3.1ppm
× 100% (7)
WPEGd(%) =
DSPEGd×Mw PEGd
(DSPEGd×Mw PEGd) + (100% × Mw DADPCS monomer)+
(
DSg3 × Mw galactose
)
× 100% (8)
2.4. Gel permeation chromatography (GPC)
The molecular weight as well as molecular weight distribution
in terms of polydispersity of modiﬁed chitosan was  determined
by gel permeation chromatography (GPC) equipped with a refrac-
tive index detector (Shimadzu RID-10A, Japan). Two  linear columns
(UltrahydrogelTM 500 and DP 120, 7.8 × 300 mm,  Waters) were
applied and acetate buffered solution at pH 5.0 was used as the
eluting solvent at a ﬂow rate of 0.8 mL/min at 35 ◦C. The calibra-
tion curve was  constructed using different molecular weights of
poly(ethylene glycol) standards. The molecular weight of modiﬁed
chitosan was  re-calculated from the calibration curve based on the
measured retention time.
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Table 1
The deacetylation degree, molecular weight, galactosylation and pegylation of
chitosan-galactose, chitosan-galactose-mPEG, and chitosan-galactose-PEGd.
Chitosan-galactose Chitosan-
galactose-mPEG
Chitosan-
galactose-PEGd
DD (%) – – –
Mw (Da) 6200 8500 7600
Mn (Da) 4000 5500 5200
PD 1.56 1.54 1.46
Wg (%) 16.7 13.2 13.8
DSg (%) 18.4 27.3 28.20 W.J. Lin, W.Y. Hsu / Carbohy
.5. Galactose determination
The content of galactose grafted onto chitosan was measured
y colorimetric assay using anthrone sulfuric acid (Laurentin &
dwards, 2003). Several known concentrations of galactose solu-
ions were placed in a 96-well pre-cooled at 4 ◦C. The fresh prepared
nthrone–sulfuric acid in an ice bath was added into the 96-well.
he 96-well was heated at 90 ◦C for 6 min  followed by cooled to
oom temperature. The absorbance was determined by spectropho-
ometer at 630 nm.  The calibration curve was constructed based
n several concentrations of galactose and their absorbance. The
olymer samples were prepared according to the same procedure,
nd the corresponding concentration was re-calculated from the
alibration curve based on the measured absorbance.
.6. Cytotoxicity of galactosylated and pegylated chitosan
The cytotoxicity of Chitosan(1), Chitosan(2), and Chitosan(3)
as investigated. HepG2 cells were cultured in the modiﬁed Eagle’s
edium containing 10% fetal bovine serum, sodium bicarbonate,
onessential amino acids and sodium pyruvate. The cells were
eeded in a 96-well plate at a density of 9000 cells per well
nd maintained in a humidiﬁed incubator at 37 ◦C in 5% CO2 for
4 h. Serial dilutions of polymer solution in cultured medium were
dded into each well and incubated at 37 ◦C for 24 h. The cultured
edium without polymer solution was the control. The medium
as removed, and the MTT  solution (3-(4,5-dimethylthiazol-2-yl)-
,5-diphenyl tetrazolium was added and incubated at 37 ◦C for 4 h
Ciapetti, Cenni, Pratelli, & Pizzoferrato, 1993). The resulting forma-
an was solubilized in dimethyl sulfoxide, and the absorbance was
easured using an enzyme-linked immunosorbent assay (ELISA)
eader (Power Wave XS, BioTek, Winooski, VT) at 570 nm (Liu &
in, 2013).
.7. Preparation of polymer/pDNA polyplex
Chitosan(1), Chitosan(2), and Chitosan(3) were complexed with
egatively charged pDNA at various weight ratios of 2:1, 10:1 and
0:1. Each polymer was previously dissolved in 1% acetic solution.
he plasmid DNA was dissolved in sterile distilled water followed
y slowly added into polymer solution and stirred for 3 min. The
esulting polyplex was stood for 3 h at room temperature. The
olyplex solution was centrifuged at 16,000 × g for 30 min. The
upernatant was removed, and the distilled water was added to
e-disperse the polyplex. The particle size and zeta potential were
easured by using Zetasizer nano analyzer (Nano-ZS 90, Malvern
nstruments Ltd., Worcestershire, UK) at 25 ◦C. The morphology
f polymer/pDNA polyplex was observed by transmission electron
icroscope (Philips Tecnai F30, Philips, Netherlands). The stability
f polyplex was evaluated their particle size change during storage
t 4 ◦C for 28 days.
.8. Transfection of polymer/pDNA polyplex
The transfection of Chitosan(1)/pDNA, Chitosan(2)/pDNA, and
hitosan(3)/pDNA polyplex was evaluated in ASGPR overexpressed
epG2 cancer cells. The HepG2 cancer cells were seeded in a 6-
ell plate at a density of 6 × 105 cells/well and incubated at 37 ◦C
or 24 h. After that the medium was removed, the serum-free
EM medium containing polymer/pDNA polyplex or naked pDNA
as added into each well and incubated for 24 h. The phosphate-
uffered solution (PBS) was added after the medium was  removed.
he cell suspension was centrifuged at 1200 rpm for 5 min. The
ells were collected and resuspended in pH 7.4 PBS for ﬂow cyto-
etric analysis in the ﬂuorescence channel FL-1 at an excitation
avelength 488 nm and an emission wavelength 530 nm.  A totalWPEG (%) – 42.6 52.8
DSPEG (%) – 3.7 43.5
of 10,000 cells were analyzed for each sample, and the upper limit
of background ﬂuorescence was set no more than 1%. Data were
presented as mean ± standard deviation. Comparison between two
groups was analyzed by Student’s t-test, and the difference was
considered signiﬁcant at p < 0.05 or 0.01.
3. Results and discussion
3.1. Characterization of chitosan-galactose (Chitosan(1))
Fig. 2(C) shows the 1H NMR  spectrum of Chitosan(1). The MW
and galactosylation data of Chitosan(1) are listed in Table 1. The
Mw, Mn and polydispersity of Chitosan(1) were 6200 Da, 4000 Da,
and 1.56, respectively. The corresponding galactose grafting weight
percentage (Wg(%)) and degree of substitution (DSg1(%)) were 16.7%
and 18.4%, respectively.
3.2. Characterization of chitosan-galactose-mPEG (Chitosan(2))
PEG plays an important role in preventing nanoparticles
aggregation and avoiding nanoparticles eliminated by RES. The
galactosylated chitosan was  further pegylated by mPEG, and the
relevant characterization data of Chitosan(2) are summarized in
Table 1. The corresponding Mw, Mn and polydispersity of Chi-
tosan(2) were 8500 Da, 5500 Da, and 1.54, respectively. Fig. 2(A)
shows the 1H NMR  spectrum of Chitosan(2). The peaks a at
3.6–4.0 ppm were assigned to C3–C6 protons of chitosan and the
protons of galactose, and peak d at 3.2 ppm was assigned to C2–H
of chitosan. The peak b at 3.6–3.8 ppm was assigned to the protons
of mPEG repeat units ( CH2 CH2 O ), and peak c at 3.5 ppm was
assigned to OCH3 of mPEG. The Wg(%) and DSg2(%) of galactose cal-
culated by Eqs. (1) and (3) were 13.2% and 27.3%, respectively. The
mPEG grafting weight percentage (WmPEG%) calculated by Eq. (5)
was 42.6%, and the corresponding degree of substitution, DSmPEG%,
calculated by Eq. (4) was  3.7% based on the integration area of peak
c and peak d in 1H NMR  spectrum. The degrees of substitution of
galactose and mPEG of mPEGylated-galactosylated-chitosan devel-
oped by Zhang et al. (2009) were 0.09% and 0.3%, respectively,
which were much lower than ours. It seemed that the current
method applied to graft galactose and mPEG onto chitosan was
more efﬁcient in terms of higher grafting values than theirs.
3.3. Characterization of chitosan-galactose-PEGd (Chitosan(3))
Another approach was designed to pegylate Chitosan(1) with
short chain PEG diacid (MW  600 Da), and the relevant charac-
terization data of Chitosan(3) are summarized in Table 1. The
corresponding Mw, Mn and polydispersity of Chitosan(3) were
7600 Da, 5200 Da, and 1.46, respectively. Fig. 2(B) shows the 1H
NMR  spectrum of Chitosan(3). The peak c′ at 4.15 ppm and peak b
at 3.6 ppm were assigned to the C H next to COOH of PEG diacid
and the repeat units ( CH2 CH2 O ) of PEG diacid. The peaks
W.J. Lin, W.Y. Hsu / Carbohydrate Polymers 120 (2015) 7–14 11
Fig. 2. The 1H NMR  spectra of (A) chitosan-galactose-mPEG, (B) chitosan-galactose-PEGd, (C) chitosan-galactose, (D) mPEG, and (E) PEG diacid.
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Fig. 4. The (A) particle size (nm) and (B) zeta potential (mV) of chitosan-galactose/ig. 3. The cellular viability of chitosan-galactose, chitosan-galactose-mPEG, and
hitosan-galactose-PEGd. The values represent mean ± SD, n = 3.
 at 3.7–3.9 ppm was assigned to C3–C6 protons of chitosan and
he protons of galactose, and peak d at 3.1 ppm was assigned to
2–H of chitosan. The galactose grafting Wg(%) and DSg3(%) were
3.8% and 28.2%, respectively. The weight percentage of pegylation
WPEGd(%)) was 52.8%, and the corresponding DSPEGd(%) was 43.5%
ased on the integration area of peak c′ and peak d in 1H NMR
pectrum.
.4. Cytotoxicity of galactosylated and pegylated chitosan
Fig. 3 illustrates the cellular viability of Chitosan(1), Chitosan(2),
nd Chitosan(3) in HepG2 cells. The cytotoxicity of grafted chi-
osan was similar irrespective of the presence of PEG and PEG
hain length, and there were at least 80% cells viable at poly-
er  concentration ≤5 g/mL. All of the grafted chitosan had
C50 corresponding to 50% cytotoxicity higher than 500 g/mL. It
ndicated that the galactosylated-pegylated-chitosan had low cyto-
oxicity and was much safe being used in vivo. Kim, Shin, and Lee
1999) reported that the cytotoxicity of PEG with molecular weight
reater than 3000 Da was ignorable. Similarly, Mao  et al. (2005)
ound that the low cytotoxicity of PEG-conjugated-chitosan was
bserved in PEG Mw 5000 Da rather than 550 Da. Nevertheless,
here was no difference in cytotoxicity between mPEG (5000 Da)
nd short chain PEG diacid (600 Da) grafted chitosan in our current
tudy.
.5. Characterization of polymer/DNA polyplex
The galactosylated-pegylated-chitosan was applied as a DNA
elivery carrier. Complex of cationic chitosan and negatively
harged plasmid DNA spontaneously formed polyplex due to
lectrostatic interaction. Fig. 4(A) illustrates the particle size of
hitosan(1)/pDNA, Chitosan(2)/pDNA, and Chitosan(3)/pDNA with
arious polymer/DNA weight ratios. The particle size of Chi-
osan(2)/pDNA polyplex with polymer/pDNA weight ratio 2:1,
0:1, and 20:1 was 159.9 ± 43.0, 104.6 ± 8.1, and 98.7 ± 6.6 nm,
espectively. The compaction of DNA by Chitosan(2) was promi-
ent when polymer/DNA weight ratio was increased from 2:1
o 10:1 where the particle size was signiﬁcantly decreased. Fur-
her increase in polymer/DNA weight ratio to 20:1 did not
hange particle size too much. The sterically repulsive nature
f mPEG protected Chitosan(2)/pDNA from secondary aggrega-
ion and formed polyplex with reliable particle size in the range
f 100–200 nm.  The similar phenomenon has been reported bypDNA, chitosan-galactose-mPEG/pDNA, and chitosan-galactose-PEGd/pDNA poly-
plex with polymer/DNA weight ratios 2:1, 10:1 and 20:1. The values represent
mean ± SD, n = 3.
Kataoka, Harada, and Nagasak (2001) where the polyionic PEG-
poly(l-lysine) block copolymer was  complexed with positively
charged pDNA. They mentioned that the PEG corona surrounded
on micelle surface decreased the local dielectric constant which
facilitated DNA compacted by PEG–PLys. However, only the
2:1(w/w) polyplex of Chitosan(3)/pDNA and Chitosan(1)/pDNA
had particle size less than 200 nm. The increase of polymer
(e.g., polymer/DNA 10:1 and 20:1) was fail to sufﬁciently com-
pact DNA into polyplex of Chitosan(3) and Chitosan(1) which
resulted in quite large in particle size. The lack of steric pro-
tection by these two polymers accounted for resulting polyplex
with quite large size. All of these results implied that the
compaction of DNA by grafted chitosan was in order of Chi-
tosan(2)/pDNA > Chitosan(3)/pDNA > Chitosan(1)/pDNA, and the
best DNA compaction was  achieved by Chitosan(2). The morphol-
ogy of Chitosan(2)/pDNA polyplex is illustrated in Fig. 5.
Fig. 4(B) illustrates the zeta potential of polyplex with various
polymer/DNA weight ratios. All polyplex possessed positive charge
character in order of Chitosan(2)/pDNA (+20–30 mV)  < Chitosan(3)/
pDNA (+40–50 mV)  < Chitosan(1)/pDNA (+45–60 mV). The mPEG
polymer chains surrounded on the polyplex surface diminished the
positive charge of chitosan resulting in the lowest zeta potential
of Chitosan(2)/pDNA polyplex. The chain length of mPEG polymer
was longer than PEG diacid where mPEG formed better surface
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Fig. 6. The stability in terms of particle size change (%) of (A) chitosan-
galactose/pDNA, (B) chitosan-galactose-mPEG/pDNA, and (C) chitosan-galactose-
PEGd/pDNA polyplex during storage at 4 ◦C for 28 days. The value in each column
indicates the polydispersity index (PDI).ig. 5. The TEM image of chitosan-galactose-mPEG/pDNA polyplex with poly-
er/DNA weight ratio 20:1.
overage on Chitosan(2)/pDNA polyplex. On the other hand, the
horter chain length of PEG diacid exerted less surface coverage
han mPEG and resulted in the zeta potential of Chitosan(3)/pDNA
igher than Chitosan(2)/pDNA but less than Chitosan(1)/pDNA.
.6. Stability of polyplex
Fig. 6 illustrates the stability in terms of percentage of parti-
le size change of polyplex after storage at 4 ◦C for 28 days. Most
f Chitosan(2)/pDNA and Chitosan(3)/pDNA polyplex maintained
heir particle size at the end of 28 days except 20:1(w/w) Chi-
osan(3)/pDNA polyplex. It lost stability after storage for 21 days
here the polyplex was aggregated in terms of enlarging parti-
le size much. All of these results indicated that Chitosan(2) was
ot only capable of condensing plasmid DNA but also formed
table polyplex as compared to Chitosan(1) and Chitosan(3). The
resence of mPEG of Chitosan(2) played an important role in pre-
enting polyplex aggregation and maintaining its stable nature
here the hydrophilic PEG chains surrounded on the outer shell
f the polyplex and extended in the aqueous environment to exert
hielding effect (Betancourt et al., 2009; Lin et al., 2009; Lu et al.,
009).
.7. Transfection of polyplex
Fig. 7 illustrates the transfection efﬁciency of polyplex in
sialoglycoprotein receptor (ASGPR) overexpressed HepG2 cells.
he transfection of naked plasmid DNA (pEGFP-N1) was  simi-
ar to the negative control (MEM medium only). However, all
f the polyplex enhanced pDNA cellular transfection as com-
ared to naked DNA in order of Chitosan(1)/pDNA > Chitosan(3)/
DNA > Chitosan(2)/pDNA. Increase in polymer/DNA weight ratios
f Chitosan(1)/pDNA polyplex from 2:1 to 20:1 prominently
ncreased transfection efﬁciency in terms of producing more
reen ﬂuorescent proteins in ASGPR overexpressed HepG2 cells.
his provided the evidence to ensure the speciﬁc targeting of
alactose to ASGP receptor. The galactose grafting weight per-
entage (Wg%) of Chitosan(1), Chitosan(2) and Chitosan(3) were
6.7, 13.2 and 13.8%, respectively. Although the grafted galac-
ose of Chitosan(1) was similar to the other two  kinds of
alactosylated-pegylated-chitosan, its galactose moiety was fully
xposed and speciﬁcally bound to ASGP receptor to enhance
ellular transfection the most. Nevertheless, the shielding effectof mPEG on the surface of Chitosan(2)/pDNA polyplex dimin-
ished the speciﬁc targeting ability of galactose to ASGP receptor
resulting in the lowest cellular transfection in HepG2 cells as
compared to the other polyplex. On the other hand, the Chi-
tosan(3)/pDNA polyplex was covered by short chain PEG diacid.
The shielding effect of PEG diacid was  not so prominent as mPEG
which accounted for the cellular transfection of Chitosan(3)/pDNA
polyplex higher than Chitosan(2)/pDNA but lower than Chi-
tosan(1)/pDNA.
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. Conclusion
The galactosylated-pegylated-chitosan with asialoglycopro-
ein receptor targeting ability was developed for gene delivery.
he chitosan was chemically grafted by galactose and differ-
nt chain lengths of hydrophilic methoxy poly(ethylene glycol)
r poly(ethylene glycol) diacid. The concentration of grafted
hitosan corresponding to 50% cytotoxicity was higher than
00 g/mL. The positively charged grafted chitosan formed
olyplex with negatively charged plasmid DNA, and the com-
action of DNA by grafted chitosan was in order of Chi-
osan(2)/pDNA > Chitosan(3)/pDNA > Chitosan(1)/pDNA. All poly-
lex enhanced DNA cellular transfection as compared to naked
NA. Although Chitosan(2)/pDNA polyplex maintained its particle
ize for longest time, the shielding effect of methoxy poly(ethylene
lycol) diminished the speciﬁc targeting ability of galactose to
sialoglycoprotein receptor resulting in the lowest cellular trans-
ection in HepG2 cells. Through this study elucidated the role of
oly(ethylene glycol) in chitosan-based polyplex stability and cel-
ular transfection.
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